TG THERAPEUTICS, INC. Common Stock (par value $0.001 per share) At Market Issuance Sales AgreementAt Market Issuance Sales Agreement • May 26th, 2017 • Tg Therapeutics, Inc. • Pharmaceutical preparations • New York
TG Therapeutics, Inc. (the “Company”), confirms its agreement (this “Agreement") with Jefferies LLC, Cantor Fitzgerald & Co., FBR Capital Markets & Co., SunTrust Robinson Humphrey, Inc., Raymond James & Associates, Inc., Ladenburg Thalmann & Co. Inc. and H.C. Wainwright & Co., LLC (each individually an "Agent” and collectively, the “Agents”) as follows:
